AU2003238359A1 - Regulation of human membrane-type serine protease - Google Patents

Regulation of human membrane-type serine protease

Info

Publication number
AU2003238359A1
AU2003238359A1 AU2003238359A AU2003238359A AU2003238359A1 AU 2003238359 A1 AU2003238359 A1 AU 2003238359A1 AU 2003238359 A AU2003238359 A AU 2003238359A AU 2003238359 A AU2003238359 A AU 2003238359A AU 2003238359 A1 AU2003238359 A1 AU 2003238359A1
Authority
AU
Australia
Prior art keywords
regulation
serine protease
human membrane
type serine
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003238359A
Inventor
Annette J. Russel
Yonghong Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003238359A1 publication Critical patent/AU2003238359A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2003238359A 2002-01-28 2003-01-28 Regulation of human membrane-type serine protease Abandoned AU2003238359A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35137602P 2002-01-28 2002-01-28
US60/351,376 2002-01-28
US40529902P 2002-08-23 2002-08-23
US60/405,299 2002-08-23
PCT/EP2003/000812 WO2003064651A2 (en) 2002-01-28 2003-01-28 Regulation of human membrane-type serine protease

Publications (1)

Publication Number Publication Date
AU2003238359A1 true AU2003238359A1 (en) 2003-09-02

Family

ID=27669026

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003238359A Abandoned AU2003238359A1 (en) 2002-01-28 2003-01-28 Regulation of human membrane-type serine protease

Country Status (2)

Country Link
AU (1) AU2003238359A1 (en)
WO (1) WO2003064651A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1292684A2 (en) * 2000-06-16 2003-03-19 Incyte Genomics, Inc. Proteases
EP1309704A2 (en) * 2000-08-07 2003-05-14 Bayer Aktiengesellschaft Regulation of human membrane-type serine protease

Also Published As

Publication number Publication date
WO2003064651A2 (en) 2003-08-07
WO2003064651A3 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2001278488A1 (en) Regulation of human matriptase-like serine protease
AU2003247776A1 (en) Serine protease 16
AU8573401A (en) Regulation of human epithin-like serine protease
AU2001281967A1 (en) Regulation of human desc1-like serine protease
AU2001293718A1 (en) Regulation of human membrane-type serine protease
AU2001266089A1 (en) Regulation of human prostasin-like serine protease
AU2003250830A1 (en) Regulation of human subtilase-like serine protease
AU2003238359A1 (en) Regulation of human membrane-type serine protease
AU2002234568A1 (en) Regulation of human serine palmitoyltransferase
AU2001268967A1 (en) Regulation of human epithin-like serine protease
AU2003260316A1 (en) Regulation of human hepsin
AU2001269095A1 (en) Regulation of human caspase-1-like protease
AU2003292406A1 (en) Serine protease
AU2003250329A1 (en) Regulation of novel human asparagine-hydroxylases
AU2001279752A1 (en) Regulation of human masp-like serine protease
AU2002213949A1 (en) Regulation of human serine protease
AU2003224874A1 (en) INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
AU2001256350A1 (en) Regulation of human lysostaphin-like protease
AU2003252734A1 (en) Novel serine protease
AU2002212246A1 (en) Regulation of human serine palmitoyltransferase-like enzyme
AU2003271651A1 (en) Regulation of human pp2c-like protein phosphatase
AU2002217155A1 (en) Regulation of human otu-like cysteine protease
AU2001238721A1 (en) Human serine protease
AU2001269097A1 (en) Regulation of human epidermis-specific serine protease
AU2001267548A1 (en) Regulation of human napsin-like aspartyl protease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase